DSpace

DSpace at RU >    University Library >    Academic bibliography >

SFX Query

Title: The methionine synthase reductase 66A>G polymorphism is a maternal risk factor for spina bifida.
Author(s): Linden, I.J. van der
Heijer, M. den (157196674)
Afman, L.A.
Gellekink, H.
Vermeulen, S. (298981033)
Kluijtmans, L.A.J. (168872579)
Blom, H.J. (073808628)
Publication year: 2006
Document type: Article / Letter to editor
Journal: Journal of Molecular Medicine-JMM
ISSN: 0946-2716
Volume: vol. 84
Issue: iss. 12
Start page: p. 1047
End page: p. 1054
Abstract: The methionine synthase reductase (MTRR) enzyme restores methionine synthase (MTR) enzyme activity and therefore plays an essential role in homocysteine remethylation. In some studies, the 66A>G polymorphism in the MTRR gene was associated with increased neural tube defect (NTD) risk. Using a case-control design, we studied the association between the MTRR 66A>G polymorphism and spina bifida risk in 121 mothers, 109 spina bifida patients, 292 control women, and 234 pediatric controls. Possible interactions between the MTRR 66A>G variant and the MTR 2756A>G polymorphism, the MTHFR 677C>T variant, plasma vitamin B12, and plasma methylmalonic acid (MMA) levels were examined in the 121 mothers and 292 control women. Meta-analyses were conducted to set the results of the case-control study in the context of eligible literature on the relation between the MTRR 66A>G variant and NTD risk. Finally, a transmission disequilibrium test was performed for 82 complete mother-father-child triads to test for preferential transmission of the MTRR risk allele. In our case-control study, the MTRR 66A>G polymorphism had no influence on spina bifida risk in children [odds ratio (OR) 0.6, 95% confidence interval (CI) 0.4-1.1]. The MTRR 66GG genotype increased maternal spina bifida risk by 2.1-fold (OR 2.1, 95% CI 1.3-3.3). This risk became more pronounced in combination with the MTHFR 677TT genotype (OR 4.0, 95% CI 1.3-12.5). Moreover, we demonstrate a possible interaction between the MTRR 66GG genotype and high plasma MMA levels (OR 5.5, 95% CI 2.2-13.5). The meta-analyses demonstrated that the maternal MTRR 66GG genotype was associated with an overall 55% (95% CI 1.04-2.30) increase in NTD risk and that the MTRR 66GG genotype did not increase NTD risk in children (OR 0.96, 95% CI 0.46-2.01). These data show that the MTRR 66GG genotype is a maternal risk factor for spina bifida especially when intracellular vitamin B12 status is low.
Subject: EBP 1: Determinants in Health and Disease
UMCN 1.5: Interventional oncology
UMCN 2.2: Vascular medicine and diabetes
UMCN 5.2: Endocrinology and reproduction
Organization: UMCN Extern
Epidemiology, Biostatistics & HTA
Paediatrics
Endocrinology
Appears in Collections:Academic bibliography

Please use this identifier to cite or link to this item: http://hdl.handle.net/2066/51023

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback